Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1996
09/11/1996CN1130631A Cyclodlkano-indole and-azaindole derivatives
09/11/1996CN1130630A Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses
09/11/1996CN1130626A Adhesion receptor antagonists
09/11/1996CN1130532A Modulation of cellular activity
09/11/1996CN1130513A Medicine for treating self-biting disease for fox and preparing process thereof
09/11/1996CN1130510A Process for preparing contraceptive
09/11/1996CN1130509A Microcapsulated zinc gluconate and producing process thereof
09/11/1996CN1130508A Two medicines for treating Parkinson's disease and presenile dementia and preparing process thereof
09/11/1996CN1130507A Use of novel 1 alpha-hydroxy vitamin D4
09/11/1996CN1130506A Pharmaceutical formulations of cefaclor
09/11/1996CN1130505A Use of 5-acyl-1,4-dihydropyridines
09/11/1996CN1130485A Omega-3omega-6 fatty acid series health food
09/11/1996CN1032756C Method for preparing ursodeoxycholic acid using fowl gall as raw material
09/11/1996CN1032755C Human placental nucleic acid extracting method
09/11/1996CN1032754C Process for preparing immunostimulating 6-aryl-5,6-dihydroimidazo |2,1-b¨ thiazole derivatives
09/11/1996CN1032752C 4-carboxyl-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-formamide-1,1-dioxygen derivant and its preparation process
09/11/1996CN1032751C Thiazolidine compound, preparing process thereof and its application in medicine
09/11/1996CN1032750C Process for prepn. of ureido derivatives of poly 4-amino-2-carboxy-1-methyl compounds
09/11/1996CA2171404A1 3-benzyl-benzothiophenes
09/11/1996CA2171403A1 .alpha. substituted-1-benzyl-naphthyls
09/11/1996CA2171399A1 Substituted-3-benzyl-benzofurans
09/11/1996CA2170968A1 Preparation of d4t from 5-methyluridine
09/10/1996US5554789 Arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent
09/10/1996US5554772 N-(3-hydroxy-4-piperidinyl) dihydrobenzofuran, (dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
09/10/1996US5554756 Amino acid derivatives
09/10/1996US5554755 Acylation
09/10/1996US5554655 Method of treating HIV infection
09/10/1996US5554654 Method for enhancing the therapeutic effect of an anti-acne agent
09/10/1996US5554653 Inhibitors of HIV protease useful for the treatment of AIDS
09/10/1996US5554652 Topically applying mixture to reduce or prevent skin disorders
09/10/1996US5554651 Method of treating wrinkles using citramalic acid
09/10/1996US5554650 Mixture of diclofenac or salt with water and surfactants; side effect reduction
09/10/1996US5554646 Method for reducing body fat in animals
09/10/1996US5554645 Antineoplastic cocoa extracts and methods for making and using the same
09/10/1996US5554643 Pro-drugs for CCK antagonists
09/10/1996US5554642 Arylalkyl(thio) amides
09/10/1996US5554641 Nonpeptides as tachykinin antagonists
09/10/1996US5554639 Medicaments
09/10/1996US5554638 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
09/10/1996US5554637 Use of leflunomide for inhibiting interleukin 1 alpha
09/10/1996US5554636 N-acylated 4-hydroxphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them
09/10/1996US5554634 N-(hydroxyethyl)butanediamide derivatives
09/10/1996US5554632 Central nervous system
09/10/1996US5554631 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinyl benzimidazole derivatives
09/10/1996US5554629 Headaches
09/10/1996US5554628 Method for minimizing the uterothrophic effect of tamoxifen and tamoxifen analogs
09/10/1996US5554626 Substituted heterocyclic compounds as dopamine-reuptake inhibitors
09/10/1996US5554625 Substituted biphenylmethylimidazopyridines
09/10/1996US5554624 Imidazopyridine derivatives as angiotensin II antagonists
09/10/1996US5554623 Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates
09/10/1996US5554622 Asymmetrically substituted bisnaphthalimides
09/10/1996US5554621 Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
09/10/1996US5554620 Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
09/10/1996US5554618 Intravenously administrable aqueous solution
09/10/1996US5554614 Treatment of psychological disorders, psychoses; analgesics
09/10/1996US5554613 Quinuclidine derivatives, qualene synthase inhibitors, treatment of hypercholesterolemia, atherosclerosis and fungus infections
09/10/1996US5554612 Immunosuppressants, viricides, antitumor and antiinflammatory agents
09/10/1996US5554611 Use of coumarin derivatives
09/10/1996US5554610 Inhalational treatment of pulmonary hypertension and related conditions
09/10/1996US5554607 Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis
09/10/1996US5554604 Method of controlling male fertility
09/10/1996US5554603 Orally active derivatives of 1,3,5(10)-estratriene
09/10/1996US5554601 Administering an estrogen compound in the absence of testosterone; treatment of alzheimer*s
09/10/1996US5554600 Methods for inhibiting endometriosis
09/10/1996US5554599 22-thio vitamin D derivatives
09/10/1996US5554598 Method of treating crural or decubitus ulcer with zinc hyaluroric acid complex
09/10/1996US5554597 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
09/10/1996US5554596 Polymer with lignin units and lignoid units
09/10/1996US5554595 Selective regulation of B lymphocyte precursors by hormones
09/10/1996US5554594 Imidazolidine derivatives
09/10/1996US5554538 DNA sequences derived from papillomavirus HPV-33 genome
09/10/1996US5554384 High dose formulations of mycophenolate mofetil and mycophenolic acid
09/10/1996US5554383 Administering selective serotonin reuptake inhibitor
09/10/1996US5554381 Low flux matrix system for delivering potent drugs transdermally
09/10/1996US5554367 Compositions for treatment of glaucoma
09/10/1996US5554365 Use of cyanoacrylate adhesive compositions to inhibit acute radiation-induced skin damage
09/10/1996US5554360 Low-irritant shampoo composition
09/10/1996US5554359 Stimulating melanogenesis in human skin cells by topically applying composition comprising lysosomotropic agent capable of increasing levels of melanin in human melanocyte and topical carrier
09/10/1996US5554110 Medical ablation apparatus
09/10/1996CA2171081A1 Use of 6,7-substitute-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
09/10/1996CA2170818A1 Method of treating cardiac inflammatory disease
09/10/1996CA2067759C 3-phenyglutarimide derivatives as muscarinic receptor antagonists
09/10/1996CA2038629C Oleandomycin oximes, preparation and use thereof
09/10/1996CA2036507C 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions
09/10/1996CA2011468C Sodium n-acetylneuraminate trihydrate and method for the preparation thereof
09/10/1996CA2009890C Valproic acid
09/07/1996CA2171057A1 Corneal opacification inhibitory composition
09/07/1996CA2170824A1 N-(3-benzofuranyl)urea-derivatives
09/06/1996WO1996027008A2 Agent for treating tumours and other hyperplasia
09/06/1996WO1996027006A2 Human vegf-specific antisense oligonucleotides
09/06/1996WO1996026950A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives
09/06/1996WO1996026944A1 Clavulanic acid salts
09/06/1996WO1996026943A1 Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
09/06/1996WO1996026937A1 Prokinetic oxadiazoles
09/06/1996WO1996026935A1 2-benzyl-3-arylbenzothiophenes
09/06/1996WO1996026933A1 Novel selective inhibitors of viral or bacterial neuraminidases
09/06/1996WO1996026932A1 2-arylbenzazole compounds
09/06/1996WO1996026931A1 Optically active thiazolidinone derivatives
09/06/1996WO1996026929A1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds
09/06/1996WO1996026928A1 Novel derivatives of ethyl-1 dihydro-1,2 oxo-2 methylamino-3 quinoxaline, utilization as drugs, and pharmaceutical compositions containing them